Press "Enter" to skip to content

New patent for Jazz Pharms drug XYREM

0
Copyright © DrugPatentWatch. Originally published at New patent for Jazz Pharms drug XYREM

Annual Drug Patent Expirations for XYREM
Annual Drug Patent Expirations for XYREM

Xyrem is a drug marketed by Jazz Pharms and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for XYREM.

This drug has twenty-three patent family members in twenty-one countries.

The generic ingredient in XYREM is sodium oxybate. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Jazz Pharms drug XYREM
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions